The Leader in Office-Based Visual Electrophysiology
Electroretinography (ERG) and Visual Evoked Potential (VEP)
Diopsys, Inc. is the leading provider of office-based visual electrophysiology medical devices that help ophthalmologists and optometrists analyze the entire visual pathway for visual and neuro-visual disorders. The company provides both Visual Evoked Potential (VEP) and Electroretinography (ERG) vision testing technology. It is this technology that powers Diopsys, Inc.’s medical devices – the Diopsys® NOVA™ and Diopsys® ARGOS™ ERG and VEP Vision Testing System product series and the Enfant® Pediatric VEP Vision Testing System.
Our patented technology has been demonstrated as an effective tool in providing objective, functional information to the ophthalmologist, optometrist, and primary care physician for the most appropriate and timely treatment to prevent vision loss. This technology is used for the detection of subclinical vision disorders, comparative data for decision making when a diagnosis is equivocal/differential, and objective vision testing in children. ERG and VEP also provide data to help isolate the location of visual pathway abnormalities, monitor progression of disease, and give the physician objective, alternative testing methods when the patient or other test results have limitations.
Diopsys vision testing systems have US FDA 510k clearance. In addition, Diopsys vision testing systems have been assessed and certified as meeting the requirements of Directive 93/42/EEC. The company’s devices also carry the CE mark allowing sales in the European Union (EU).